ACXP
Acurx Pharmaceuticals Inc

1,904
Loading...
Loading...
News
all
press releases
Are Medical Stocks Lagging Acurx Pharmaceuticals (ACXP) This Year?
Zacks·3mo ago
News Placeholder
More News
News Placeholder
Waters Q1 Earnings Surpass Estimates, Revenue Rise Y/Y
chainwire·4mo ago
News Placeholder
Acurx Announces Publication of Positive Results from an In-Silico Study Predicting the Microbiome-Restorative Potential of Ibezapolstat in the Treatment of CDI
Acurx Announces Publication of Positive Results from an In-Silico Study Predicting the Microbiome-Restorative Potential of Ibezapolstat in the Treatment of CDI Acurx Announces Publication of Positive...
PR Newswire·7mo ago
News Placeholder
JPO Grants Acurx Pharmaceuticals Patent in Japan for DNA Polymerase IIIC Inhibitors
JPO Grants Acurx Pharmaceuticals Patent in Japan for DNA Polymerase IIIC Inhibitors JPO Grants Acurx Pharmaceuticals Patent in Japan for DNA Polymerase IIIC Inhibitors PR Newswire STATEN ISLAND...
PR Newswire·7mo ago
News Placeholder
Acurx Pharmaceuticals, Inc. Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Acurx Pharmaceuticals, Inc. Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules Acurx Pharmaceuticals, Inc. Announces Closing of $2.5 Million...
PR Newswire·8mo ago
News Placeholder
Acurx Pharmaceuticals, Inc. Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Acurx Pharmaceuticals, Inc. Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules Acurx Pharmaceuticals, Inc. Announces $2.5 Million Registered Direct Offering...
PR Newswire·8mo ago
News Placeholder
Acurx Receives Positive Regulatory Guidance from EMA for Ibezapolstat Phase 3 Program for C. Difficile Infection (CDI)
Acurx Receives Positive Regulatory Guidance from EMA for Ibezapolstat Phase 3 Program for C. Difficile Infection (CDI) Acurx Receives Positive Regulatory Guidance from EMA for Ibezapolstat Phase 3...
PR Newswire·8mo ago
News Placeholder
Acurx Updates Phase 3 Readiness for Ibezapolstat in C. difficile Infection Based on Recent FDA and EMA Communications
Acurx Updates Phase 3 Readiness for Ibezapolstat in C. difficile Infection Based on Recent FDA and EMA Communications Acurx Updates Phase 3 Readiness for Ibezapolstat in C. difficile Infection Based...
PR Newswire·9mo ago
News Placeholder
Bitcoin Briefly Eclipses $99K Why Investors Just Can't Get Enough
Thomas Trutschel / Contributor / Getty ImagesKey TakeawaysBitcoin rose above $98,000 for the first time on Thursday.This marks a 46% increase since Donald Trump was announced as the winner of the...
Investopedia Headlines·10mo ago
News Placeholder
Acurx Board of Directors Approves Bitcoin as Treasury Reserve Asset
Acurx Board of Directors Approves Bitcoin as Treasury Reserve Asset Acurx Board of Directors Approves Bitcoin as Treasury Reserve Asset PR Newswire STATEN ISLAND, N.Y., Nov. 20, 2024 STATEN ISLAND...
PR Newswire·10mo ago

Latest ACXP News

View

Advertisement. Remove ads.

Advertisement. Remove ads.